South Korea vs Sub-Saharan Africa (IDA & IBRD countries): Immunization, Hib3 (% of children ages 12-23 months)
Immunization, Hib3 (% of children ages 12-23 months) over time
- South Korea
- Sub-Saharan Africa (IDA & IBRD countries)
How they compare
South Korea currently reports 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 23.0%.
That makes South Korea's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 11 years both countries report, South Korea has been ahead every year.
South Korea ranks 29th and Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd of 191 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Sub-Saharan Africa (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 97.5% | 73.0% | 24.5% | South Korea |
| 2020s | 96.6% | 73.4% | 23.2% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, South Korea or Sub-Saharan Africa (IDA & IBRD countries)?
- South Korea, at 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between South Korea and Sub-Saharan Africa (IDA & IBRD countries)?
- 23.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Sub-Saharan Africa (IDA & IBRD countries)?
- 11 years are reported by both, from 2014 to 2024.
- How do South Korea and Sub-Saharan Africa (IDA & IBRD countries) rank globally for immunization, hib3?
- South Korea ranks 29th and Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.